Integration of Braille Prescription Medication (BPM) Label in Medical Paper Packet for Selected Over-The-Counter Drugs among Visually Impaired Young Adults

Visually impaired individuals face significant challenges in independently managing their medications due to the inaccessibility of standard prescription labels, often resulting in medication errors and poor adherence. To address this gap, Braille Prescription Medication (BPM) labels were introduced to promote autonomy and safety in medication use. This study aimed to determine the levels of knowledge, perception, and satisfaction among visually impaired young adults after utilizing BPM labels, and to assess the relationships among these variables. A post-test quasi-experimental design was employed, involving thirty (30) visually impaired young adults selected through purposive sampling. Braille-integrated labels were developed and applied to selected over-the-counter (OTC) drugs. A validated questionnaire measured respondents’ knowledge, perception, and satisfaction. Findings revealed BPM labels moderately enhanced knowledge (overall mean 0.75), with excellent comprehension of basic details like brand name (1.00) but poor understanding of side effects (0.267). Perception was low (overall mean 1.60), reflecting limited prior exposure, while satisfaction was very high (overall mean 4.76), boosting independence and adherence. Correlations were negligible, indicating satisfaction stems from practical use rather than prior awareness. The integration of BPM labels effectively enhanced medication understanding and satisfaction among visually impaired young adults. Despite limited prior exposure, the initiative fostered independence and confidence, underscoring the need for broader implementation and greater advocacy for accessible labeling systems.